Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The updates appear to be cosmetic, with only formatting/layout adjustments to the Study Details page and no changes to core trial content such as design, eligibility criteria, interventions, primary/secondary outcomes, or listed sites. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:38:03.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Update: revision number upgraded from v3.0.2 to v3.2.0, indicating a new release. No other content changes detected.
    Difference
    0.1%
    Check dated 2025-10-01T04:43:12.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Upgrade of the page version from v3.0.2 to v3.1.0; a metadata/versioning change with no impact on core content or user-facing data.
    Difference
    0.1%
    Check dated 2025-09-30T03:42:34.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed; overall content remains unchanged.
    Difference
    0.1%
    Check dated 2025-09-15T19:32:34.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-08T15:53:50.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a list of recent publications related to breast cancer treatments. Notably, several locations in Russia and South Korea have been added, while some previous location entries have been removed.
    Difference
    15%
    Check dated 2025-08-31T12:13:51.000Z thumbnail image

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.